Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Non-Small Cell Lunch Cancer × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 61 Breast Neoplasms 48 Ovarian Neoplasms 37 Lung Neoplasms 20 Neoplasms 19 Carcinoma, Ovarian Epithelial 18 Fallopian Tube Neoplasms 17 Neoplasm Metastasis 14 Recurrence 8 Head and Neck Neoplasms 8 Adenocarcinoma of Lung 8 Triple Negative Breast Neoplasms 7 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Uterine Cervical Neoplasms 6 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Pancreatic Neoplasms 5 Uterine Neoplasms 4 Urinary Bladder Neoplasms 4 Solid Tumors 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Adenocarcinoma Of Esophagus 4 Testicular Neoplasms 3 Solid Tumor 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Squamous Cell 3 Carcinoma 3

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡